Leanna Caron

Biography

Mrs. Leanna Caron serves as Vice President and General Manager of Cell Therapy and Regenerative Medicine at Sanofi-Genzyme. Mrs. Caron managed the global commercial operations for Cell Therapy & Regenerative Medicine. She has served as a senior healthcare executive for the past 20 years. She has an impressive list of accomplishments in business management and development. Her leadership of the cell therapy business, including cartilage repair products, covered oversight of regulatory affairs, manufacturing, business development, commercial operations and strategic planning. She is one of the few global executives who have led commercial development of globally marketed cartilage repair products. Throughout her career, She has been vice chairman at Kuros Biosciences AG since June 16, 2016. Mrs. Caron has demonstrated a deep understanding and a proven success record in leading international teams to successfully launch blockbuster as well as niche and orphan products. In addition to her most recent role with Sanofi, she has held senior positions at Genzyme and Merck in the United States, Canada and Europe. She has been a Director at Cartiheal Ltd. since December 2013 and Kuros Biosciences AG since June 16, 2016. She was an advisory board member of WEST (Advancing Women in the Business of Science and Technology). In March 2013, Mrs. Caron was named as one of the top 50 Global Stem Cell Influencers.

Research Interest

Cell Therapy and Regenerative Medicine